Reach Us +1-217-403-9671
Bioinformatics, Drugs & Omics- An Overview Of The Major Areas Of The Omics | 7566
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Bioinformatics, drugs & omics- An overview of the major areas of the omics

2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

S. M. Zahid Hosen

Accepted Abstracts: Pharmaceut Reg Affairs

DOI: 10.4172/2167-7689.S1.008

Bioinformatics is becoming more and more important in drug discovery and drug development and is tightly integrated with various omics technologies and other high through throughput technologies. The automated omics technologies which have followed the genomics revolution generate very large amounts of data, and it is the task of bioinformatics to take care of these data and make practical use of them. Omics is used in words such as genomics, transcriptomics, proteomics, metabolomics, and interactomics. Omics produces very large amount of data and these data accumulate at an ever increasing speed. The amounts of data are so large that it is impossible for a human brain to encompass even a tiny fraction of them and even if we could, making practical use of them would be an even more difficult task. It is evident therefore that computers are needed to translate the data into formats that can be understood and interpreted by humans. In this study we have concentrated on describing the methods for data acquisition in omics and some features of the underlying biology that are essential for interpreting the results from the data generated . Omics technologies thus aim at studying the organism in their entirety. Based on the knowledge gained it is hoped that we will be able to develop drug faster and more efficiently.
Mr. S. M. Zahid Hosen has been working as a Lecturer, in the Department of Pharmacy, BGC Trust University, Bangladesh from January 2009 to till the date. Mr. Hosen has published more than 25 research and review papers in reputed International and national Journal. He participated in many seminars and conferences in home and abroad to present his research activities. His research work based on Infectious diseases, Pharmacology, Molecular biology, Cancer biology, Pharmaceutical Biotechnology and Pharmaceutical bioinformatics. After completion of his Master of Pharmacy (Thesis) with distinction he successfully completed course on Pharmaceutical Bioinformatics from world renowned Uppsala University, Sweden. He is a fellow of Academy of General Education, India (FAGE) and also life member of Association of Pharmacy Professionals, India. He is interested in Molecular Medicine, Pharmacogenomics and Pharmaceutical Bioinformatics. At present Mr. Hosen conducted his research work as a project leader (Pharmaceutical Biotechnology) in the ?Genomics and Bioinformatics Lab-USTC? under supervision of renowned scientist Professor Dr. Arifuzzaman.